1. Home
  2. DDS vs RNA Comparison

DDS vs RNA Comparison

Compare DDS & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dillard's Inc.

DDS

Dillard's Inc.

HOLD

Current Price

$582.23

Market Cap

9.5B

ML Signal

HOLD

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$13.75

Market Cap

227.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDS
RNA
Founded
1938
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
227.6M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
DDS
RNA
Price
$582.23
$13.75
Analyst Decision
Sell
Buy
Analyst Count
3
20
Target Price
$519.67
$69.26
AVG Volume (30 Days)
125.1K
2.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.06
$88.12
Revenue Next Year
$2.02
$18.11
P/E Ratio
$18.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$282.24
$13.06
52 Week High
$741.98
$73.06

Technical Indicators

Market Signals
Indicator
DDS
RNA
Relative Strength Index (RSI) 38.82 5.62
Support Level $519.06 $13.06
Resistance Level $634.02 $72.52
Average True Range (ATR) 25.72 0.99
MACD -3.73 -2.13
Stochastic Oscillator 17.00 1.21

Price Performance

Historical Comparison
DDS
RNA

About DDS Dillard's Inc.

Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: